Future Fund LLC boosted its stake in HealthEquity, Inc. (NASDAQ:HQY – Free Report) by 14.1% in the first quarter, according to its most recent disclosure with the Securities and Exchange Commission. The fund owned 50,580 shares of the company’s stock after purchasing an additional 6,263 shares during the quarter. HealthEquity comprises about 1.5% of Future Fund LLC’s investment portfolio, making the stock its 12th largest holding. Future Fund LLC’s holdings in HealthEquity were worth $4,227,000 as of its most recent filing with the Securities and Exchange Commission.
Other hedge funds have also recently added to or reduced their stakes in the company. Fifth Third Wealth Advisors LLC boosted its holdings in HealthEquity by 4.2% during the first quarter. Fifth Third Wealth Advisors LLC now owns 2,872 shares of the company’s stock worth $240,000 after buying an additional 116 shares during the last quarter. Truist Financial Corp increased its stake in shares of HealthEquity by 4.9% in the 4th quarter. Truist Financial Corp now owns 2,537 shares of the company’s stock valued at $232,000 after acquiring an additional 119 shares during the last quarter. Fiduciary Trust Co increased its stake in shares of HealthEquity by 3.4% in the 3rd quarter. Fiduciary Trust Co now owns 3,669 shares of the company’s stock valued at $348,000 after acquiring an additional 120 shares during the last quarter. Larson Financial Group LLC raised its position in shares of HealthEquity by 24.4% in the 3rd quarter. Larson Financial Group LLC now owns 628 shares of the company’s stock valued at $60,000 after acquiring an additional 123 shares during the period. Finally, GAMMA Investing LLC raised its position in shares of HealthEquity by 9.5% in the 4th quarter. GAMMA Investing LLC now owns 1,944 shares of the company’s stock valued at $178,000 after acquiring an additional 168 shares during the period. Institutional investors and hedge funds own 99.55% of the company’s stock.
Insider Activity
In related news, EVP Michael Henry Fiore sold 3,142 shares of the firm’s stock in a transaction on Friday, May 29th. The shares were sold at an average price of $95.00, for a total transaction of $298,490.00. Following the sale, the executive vice president directly owned 59,113 shares in the company, valued at $5,615,735. This trade represents a 5.05% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the SEC, which is available at this hyperlink. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, EVP Delano Ladd sold 7,500 shares of the business’s stock in a transaction on Thursday, May 28th. The shares were sold at an average price of $90.00, for a total transaction of $675,000.00. Following the completion of the sale, the executive vice president directly owned 91,141 shares in the company, valued at $8,202,690. This represents a 7.60% decrease in their ownership of the stock. The SEC filing for this sale provides additional information. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Insiders sold 17,905 shares of company stock worth $1,651,280 over the last quarter. 1.60% of the stock is currently owned by company insiders.
Analyst Upgrades and Downgrades
Check Out Our Latest Stock Report on HQY
HealthEquity Trading Down 1.0%
NASDAQ:HQY opened at $97.67 on Friday. The company has a debt-to-equity ratio of 0.46, a current ratio of 3.44 and a quick ratio of 3.44. The business’s 50-day simple moving average is $88.76 and its 200-day simple moving average is $84.78. HealthEquity, Inc. has a fifty-two week low of $72.76 and a fifty-two week high of $105.96. The stock has a market capitalization of $8.17 billion, a PE ratio of 36.58, a price-to-earnings-growth ratio of 1.66 and a beta of 0.21.
HealthEquity (NASDAQ:HQY – Get Free Report) last posted its earnings results on Thursday, May 28th. The company reported $1.24 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $1.11 by $0.13. The business had revenue of $354.64 million during the quarter, compared to analysts’ expectations of $352.02 million. HealthEquity had a return on equity of 14.75% and a net margin of 17.25%.HealthEquity’s revenue was up 7.2% on a year-over-year basis. HealthEquity has set its FY 2027 guidance at 2.880-2.950 EPS. Sell-side analysts expect that HealthEquity, Inc. will post 3.92 earnings per share for the current fiscal year.
HealthEquity Profile
HealthEquity, Inc (NASDAQ: HQY) is a leading administrator of consumer-directed health accounts and related benefit solutions in the United States. Founded in 2002 and headquartered in Draper, Utah, the company specializes in health savings accounts (HSAs) and offers complementary services such as flexible spending accounts (FSAs), health reimbursement arrangements (HRAs), COBRA administration and commuter benefits. Through its technology-driven platform, HealthEquity enables employers, health plans and individuals to streamline account management, improve cost transparency and encourage more informed healthcare spending.
Serving millions of members across all 50 states, HealthEquity leverages an open-architecture ecosystem that integrates with health plans, payroll providers and financial institutions.
Read More
- Five stocks we like better than HealthEquity
- AST SpaceMobile Stock Sinks as SpaceX Fallout Rattles Space Sector
- Aehr Test Systems Stock Soars on Earnings, Eyes Over 150% Revenue Growth
- TSMC Just Gave AI Chip Bulls Another Reason to Stay Confident
- GE Aerospace Faces a Prove-It Moment in Q2 Earnings
Want to see what other hedge funds are holding HQY? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for HealthEquity, Inc. (NASDAQ:HQY – Free Report).
Receive News & Ratings for HealthEquity Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for HealthEquity and related companies with MarketBeat.com's FREE daily email newsletter.
